S. Bašić-Kinda

发表

Serum chitotriosidase: a circulating biomarker in polycythemia vera

R. Zadro, I. Aurer, N. Duraković, 2018, Hematology.

High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin’s lymphoma

S. Mazič, M. Kralik, B. Labar, 2016, Annals of Hematology.

Influence of Blood Count, Cardiovascular Risks, Inherited Thrombophilia, and JAK2 V617F Burden Allele on Type of Thrombosis in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms.

R. Zadro, B. Labar, I. Aurer, 2019, Clinical lymphoma, myeloma & leukemia.

Multiparameter flow cytometry is necessary for detection, characterization and diagnostics of composite mature B-cell lymphoproliferative neoplasms

I. Aurer, I. Ugrina, A. Duletić-Načinović, 2013, International Journal of Hematology.

Comparison of Different Schedules of Rituximab and Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of Krohem

I. Aurer, I. Radman, O. Jakšić, 2021, Journal of Cancer Science and Clinical Therapeutics.

Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases

I. Aurer, B. Coha, D. Radic-Kristo, 2021, Croatian medical journal.

GINGIVAL ULCERATIONS IN A PATIENT WITH ACUTE MYELOID LEUKEMIA: A case report and literature review

I. Aurer, V. Vucicevic Boras, S. Bašić-Kinda, 2019, Acta clinica Croatica.

The Genetic Basis of Hepatosplenic T-cell Lymphoma.

D. Dunson, I. Lossos, W. Chan, 2017, Cancer discovery.

Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017

I. Aurer, R. Vrhovac, I. Kardum-Skelin, 2018, Acta clinica Croatica.

The cellular story of dishevelleds

N. Pećina-Šlaus, A. Kafka, S. Bašić-Kinda, 2014, Croatian medical journal.

Epstein-Barr virus-negative aggressive natural killer-cell leukaemia with high P-glycoprotein activity and phosphorylated extracellular signal-regulated protein kinases 1 and 2

I. Aurer, J. Babel, V. Gašparović, 2012, Hematology reports.

CD43 expression is an adverse prognostic factor in diffuse large B-Cell lymphoma.

B. Labar, I. Aurer, M. Nola, 2009, Clinical lymphoma & myeloma.

R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience

M. Kralik, I. Aurer, I. Radman, 2020, Annals of Hematology.

Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group

M. Gregor, S. Levi, M. Nijziel, 2020, American journal of hematology.

Terminal deoxynucleotidyl transferase negative T-cell lymphoblastic lymphoma in aleukemic patient

I. Brčić, B. Labar, M. Nola, 2008, International journal of hematology.

Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group

M. Dimopoulos, E. Katodritou, E. Terpos, 2021, Journal of clinical medicine.

Author reply

I. Aurer, S. Dotlić, I. Radman, 2018, Internal medicine journal (Print).

Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients

B. Labar, I. Radman, D. Šegulja, 2015, Croatian medical journal.

Haematopoietic stem cell mobilization with plerixafor and G‐CSF in patients with multiple myeloma transplanted with autologous stem cells

W. Wiktor-Jedrzejczak, G. Basak, B. Labar, 2011, European journal of haematology.

Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it’s not too late

W. Wiktor-Jedrzejczak, G. Basak, B. Labar, 2011, Leukemia & lymphoma.

High incidence of aseptic hip necrosis in Hodgkin lymphoma patients treated with escalated BEACOPP receiving methylprednisolone

I. Aurer, S. Dotlić, Z. Perić, 2018, Internal medicine journal.

Comparison of Branded and Generic Imatinib Plasma Concentrations in Patients With Chronic Myelogenous Leukemia: Unicentric Study.

R. Zadro, I. Radman, Z. Perić, 2016, Clinical lymphoma, myeloma & leukemia.

Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem

I. Aurer, D. Pulanić, D. Šegulja, 2022, Biomedicines.

Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases

V. Milunović, I. Aurer, B. Coha, 2022, HemaSphere.

Purine Analogues Increase the Risk of Lethal and/or Prolonged COVID19 While Obinutuzumab Increases the Risk of Prolonged but Not Lethal Infection in Patients Treated for Lymphoid Malignancies -a Study of Krohem, the Croatian Group for Hematologic Diseases

I. Aurer, H. Holik, O. Jakšić, 2021, Blood.

Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab

B. Labar, I. Aurer, M. Nola, 2009, International journal of hematology.

[Treatment of hairy cell leukemia with cladribine].

B. Labar, I. Aurer, J. Jakić-Razumović, 2007, Lijecnicki vjesnik.

Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphoma

M. Kralik, I. Aurer, I. Radman, 2023, Medicine.

FNA based diagnosis of head and neck nodal lymphoma.

B. Labar, I. Aurer, I. Radman, 2010, Collegium antropologicum.

N. Jonjić, B. Labar, I. Seili-Bekafigo, 2014, Annals of Hematology.

Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience

I. Aurer, Inga Mandac Smoljanović, F. Šantek, 2023, La radiologia medica.

PB1669 RISK FACTORS FOR THROMBOEMBOLISM IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

I. Aurer, I. Radman, D. Pulanić, 2019, HemaSphere.

H. Holik, S. Bašić-Kinda, Slobodanka Ostojić-Kolonić, 2024, Biomedicines.

Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins’s Lymphoma Patients—A Single Centre Experience

Inga Mandac Smoljanović, F. Šantek, S. Bašić-Kinda, 2024, Cancers.

Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP)

I. Radman, Margareta Dobrenić, S. Bašić-Kinda, 2024, Medicina.